Clinical Trials Browser

Phase 3 × Unknown × Erlotinib Hydrochloride × Clear all

NCT02633189 2023-03-24

BEVERLY

Phase 3 Unknown

Non-squamous Non-small Cell Lung Cancer

NCT02140333 2015-02-12

Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC

Phase 3 Unknown

NSCLC

NCT00686114 2014-04-29

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

Phase 3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02001896 2013-12-05

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00989690 2013-08-12

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00955695 2013-08-02

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00440167 2012-07-09

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00637910 2012-02-24

TAILOR

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis